Vivos (RDGL) Accumulated Depreciation & Amortization (2011 - 2025)

Vivos' (RDGL) quarterly Accumulated Depreciation & Amortization came in at -$1612.0 in Q4 2025, down 110.62% quarter-over-quarter from $15182.0 in Q1 2018.

Vivos (RDGL) Accumulated Depreciation & Amortization (2011 - 2025) Analysis & Trends

Vivos has disclosed Accumulated Depreciation & Amortization across 9 years of filings, most recently posting -$1612.0 for Q4 2025.

  • Accumulated Depreciation & Amortization for Q4 2025 came in at -$1612.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was -$1612.0 (changed N/A YoY), and the FY2025 annual result was -$1612.0, changed N/A from the prior year.
  • Accumulated Depreciation & Amortization came in at -$1612.0 for Q4 2025 at Vivos, down from $15182.0 in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of -$1612.0 in Q4 2025 to a low of -$1612.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn
10 Vivos - - -3,105.00

Historic Data

Download Data
DateValue
Dec 31, 2025 -1,612.00
Dec 31, 2025 -1,612.00
Mar 31, 2018 15,182.00
Mar 31, 2018 15,182.00
Dec 31, 2017 1,473.00
Dec 31, 2017 1,473.00
Mar 31, 2017 29,042.00
Mar 31, 2017 29,042.00
Dec 31, 2016 2,947.00
Dec 31, 2016 2,947.00
Sep 30, 2016 1.40 Mn
Sep 30, 2016 1.40 Mn
Jun 30, 2016 1.40 Mn
Jun 30, 2016 1.40 Mn
Mar 31, 2016 2.42 Mn
Mar 31, 2016 2.42 Mn
Dec 31, 2015 5,672.00
Dec 31, 2015 5,672.00
Sep 30, 2015 2.61 Mn
Sep 30, 2015 2.61 Mn